National recommendations for the management of children and young people with IgA vasculitis: a best available evidence, group agreement-based approach
2024

National Guidelines for Managing IgA Vasculitis in Children

Sample size: 28 publication 10 minutes Evidence: moderate

Author Information

Author(s): Louise Oni, Caroline Platt, Matko Marlais, Liza McCann, Farah Barakat, Markus Hesseling, Hannah Cottis, Sue Protheroe, Gabrielle Haigh, Kerstin Nott, Julien Marro, Elizabeth King, Jane Kelly, Jill Sussens, Shirley Mulvaney, Thomas Whitby, Iona Morgan, Amita Sharma, Reem Al-Jayyousi, Chee Kay Cheung, Christopher Ng, Anthony David Lander, William Simmons, Charlotte Melling, Rebecca Grandison, Leanne Treitl, Alan D Salama, Jan Dudley

Primary Institution: University of Liverpool

Hypothesis

Can a best available evidence, group agreement-based approach develop national recommendations for the management of IgA vasculitis in children?

Conclusion

A national standardised approach to the clinical management of IgA vasculitis in children has been achieved despite the rarity of the disease.

Supporting Evidence

  • IgA vasculitis is the most common type of vasculitis in children.
  • Most children recover fully, but some may develop chronic kidney disease.
  • The guidelines were endorsed by the UK Kidney Association and Royal College of Paediatrics and Child Health.
  • Evidence synthesis included 82 relevant papers for developing recommendations.
  • Recommendations were based on a multiprofessional approach and open consultation.

Takeaway

This study created guidelines to help doctors treat children with a rare disease called IgA vasculitis, making sure all kids get the same good care.

Methodology

A multiprofessional guideline development group met monthly to generate recommendations based on systematic literature review and open consultation.

Potential Biases

Potential biases may arise from the limited evidence base and the subjective nature of group consensus.

Limitations

The study faced limitations due to the lack of high-quality evidence and the evolving nature of research in this area.

Participant Demographics

The guideline development group included 28 members from various medical specialties, including general paediatricians and nephrologists.

Digital Object Identifier (DOI)

10.1136/archdischild-2024-327364

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication